Bortezomib and Azacitidine in Treating Patients With Relapsed or Refractory T-Cell Lymphoma
This study is ongoing, but not recruiting participants.
Sponsor:
Pierluigi Porcu
Collaborators:
Millennium Pharmaceuticals, Inc.
Celgene Corporation
Information provided by (Responsible Party):
Pierluigi Porcu, Ohio State University Comprehensive Cancer Center
ClinicalTrials.gov Identifier:
NCT01129180
First received: May 17, 2010
Last updated: February 18, 2013
Last verified: February 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is ongoing, but not recruiting participants. |
|---|---|
| Estimated Study Completion Date: | No date given |
| Estimated Primary Completion Date: | May 2013 (Final data collection date for primary outcome measure) |